AXIM Biotechnologies's total assets for Q4 2024 were $3.45M, a decrease of -4.12% from the previous quarter. AXIM total liabilities were $13.87M for the fiscal quarter, a 1.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.